Clinical Trials Logo

Cubital Tunnel Syndrome clinical trials

View clinical trials related to Cubital Tunnel Syndrome.

Filter by:

NCT ID: NCT06117501 Recruiting - Clinical trials for Recurrent Cubital Tunnel Syndrome

Nerve Protection Evaluation: Revision Cubital Tunnel Syndrome Decompression

COVERED
Start date: October 19, 2023
Phase: N/A
Study type: Interventional

This single-cohort, prospective case series is designed to evaluate and characterize the use of Axoguard HA+ Nerve Protectorâ„¢ to protect the ulnar nerve in a first revision cubital tunnel decompression procedure. Data on the primary cubital tunnel syndrome decompression, first revision decompression utilizing Axoguard HA+ Nerve Protector, participant-reported pain, motor and sensory functional outcomes, quality of life (QoL) outcomes, and recurrence/revision will be collected. This case series will help to establish the ability of Axoguard HA+ Nerve Protector to provide clinical benefits for patients undergoing a first revision cubital tunnel decompression procedure.

NCT ID: NCT06095011 Recruiting - Clinical trials for Cubital Tunnel Syndrome

Posture Correction in Cubital Tunnel Syndrome

Start date: December 15, 2023
Phase: N/A
Study type: Interventional

The primary objective of this study is to determine whether the UpRight Go posture trainer reduces the symptoms of cubital tunnel syndrome in patients who have not had corrective surgery, as determined by improvements in VAS scores for pain, numbness, and weakness.

NCT ID: NCT06090877 Not yet recruiting - Clinical trials for Ulnar Nerve Compression

US and Shear Wave Elastography in Cubital Tunnel Syndrome

Start date: November 1, 2023
Phase:
Study type: Observational

This study aims to assess the role of US and SWE in diagnosis of CuTS and localization of its underlying etiology and verifying whether it can be diagnosed and graded based on US findings, especially quantitaive ulnar nerve stiffness data obtained using SWE, compared to ENMG and intraoperative findings (as gold standard)

NCT ID: NCT06086210 Completed - Clinical trials for Ulnar Nerve Entrapment at Elbow

Evaluation of the Efficacy of Low Level Laser Therapy in Ulnar Neuropathy at the Elbow

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is, to demonstrate the effectiveness of low-level laser therapy on symptoms, clinical and electrophysiological parameters in elbow ulnar neuropathy.

NCT ID: NCT05931731 Not yet recruiting - Clinical trials for Cubital Tunnel Syndrome

Mechanical Interference Versus Neural Mobilization on Ulnar Neuropathy Post Cubital Tunnel Syndrome

CTS
Start date: June 30, 2023
Phase: N/A
Study type: Interventional

this study will be conducted to compare between mechanical interference and neural mobilization on ulnar neuropathy post-cubital tunnel syndrome

NCT ID: NCT05395715 Recruiting - Clinical trials for Cubital Tunnel Syndrome

Conditioning Electrical Stimulation to Improve Outcomes in Cubital Tunnel Syndrome

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

Cubital tunnel syndrome is the second most common compression neuropathy. In severe cases, functional recovery, even with surgery, is often poor. Therefore, alternative adjunct treatments capable of increasing the speed of nerve regeneration are much needed.

NCT ID: NCT05332405 Withdrawn - Clinical trials for Cubital Tunnel Syndrome

SPY Angiography To Assist With Ulnar Nerve Transposition at the Elbow

Start date: May 26, 2022
Phase: Phase 4
Study type: Interventional

Patients with vascular disease, thyroid disease or an allergy to indocyanine green (ICG) will be excluded. Patients with either median or ulnar nerve compression will be treated with nerve decompression. SPY angiography will be used to assess the vascularity of the nerve both pre and post release as the primary outcome measure.

NCT ID: NCT05242302 Completed - Surgery Clinical Trials

AIN Transfer for Cubital Tunnel Syndrome

Start date: January 1, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Ulnar nerve compressive injury due to cubital tunnel syndrome is very common. Because of the long distance to the target muscles in the hand, functional outcome in severe cases even with decompression surgery is often poor. Therefore, alternative treatment options are much needed. Recently, anterior interosseous nerve reverse end to side (RETS) transfer to the ulnar nerve above the wrist has gained popularity. However, whether a substantial portion of motor axons in the donor nerve are indeed capable of breaching the connective tissues in the ulnar nerve to reach the target muscles in the hand remains untested. To answer this crucial question, in this study the investigators plan to recruit 60 cubital tunnel syndrome patients with marked motor axonal loss who will undergo the RETS procedure. Motor unit number estimation will be done on the ulnar and anterior interosseous nerves at baseline and repeated at 3 and 6 months post operatively. Hand motor function and disability scores will also be tested at the same time points. Given the importance of this critical question and the potential utilities of distal nerve transfers, this should be a worthwhile effort.

NCT ID: NCT05212311 Completed - Clinical trials for Cubital Tunnel Syndrome

Effect of Chitosan Phonophoresis On Cubital Tunnel Syndrome

Start date: March 8, 2022
Phase: N/A
Study type: Interventional

- This study will be conducted to answer the following question: Is there a statistically significant effect of chitosan phonophoresis on ulnar nerve conduction velocity, pain level & function in patients with mild to moderate cubital tunnel syndrome? - Fifty-four subjects suffering from mild to moderate cubital tunnel syndrome according to modified McGowan grading system (Palmer & Hughes, 2010) from both sexes diagnosed clinically by electromyography will be recruited for this study. The Age of the participants will range from 20 - 40 years old. Participants with Body mass index between 18.5 and 24.9kg/m2. EMS physio Ltd ultrasound device will be used in combination with chitosan nanoparticles gel. Electrodiagnostic test will be performed for ulnar nerve conduction velocity using Neuropack S1 MEB-9004 NIHON KODEN, JAPAN. Visual analogue scale (VAS) will be used to determine pain level. Quick DASH will be used to determine hand function.Patients will have 3 sessions per week for 5 weeks.

NCT ID: NCT04662320 Recruiting - Nerve Injury Clinical Trials

Promoting Healing Of Nerves Through Electrical Stimulation

PHONES
Start date: September 1, 2021
Phase: N/A
Study type: Interventional

This study is evaluating a new therapeutic use of electrical stimulation to promote nerve healing and improve functional recovery following surgical intervention for nerve compression. A single dose of the therapeutic stimulation is delivered as part of the surgical intervention to address compression of the ulnar nerve at the elbow.